Canlyniadau Chwilio - Hsiao‐Yi Lin
- Dangos 1 - 13 canlyniadau o 13
-
1
-
2
-
3
-
4
-
5
Risk of tuberculosis with anti‐tumor necrosis factor‐α therapy: substantially higher number of patients at risk in <scp>A</scp>sia gan Sandra Navarra, Boxiong Tang, Liangjing Lu, Hsiao‐Yi Lin, Chi Chiu Mok, Paijit Asavatanabodee, Parawee Suwannalai, Heselynn Hussein, Mahboob U. Rahman
Cyhoeddwyd 2013Artigo -
6
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study gan Naomi Schlesinger, Eduardo Mysler, Hsiao‐Yi Lin, Marc De Meulemeester, Jozef Rovenský, Udayasankar Arulmani, Alison Balfour, Gerhard Krammer, Peter Sallstig, A. So
Cyhoeddwyd 2011Artigo -
7
Effect of Urate-lowering Therapy on the Risk of Cardiovascular Disease and All-cause Mortality in Patients with Gout: A Case-matched Cohort Study gan Jiunn‐Horng Chen, Joung‐Liang Lan, Chi‐Fung Cheng, Wen‐Miin Liang, Hsiao-Yi Lin, Gregory J. Tsay, Wen‐Ting Yeh, Wen‐Harn Pan
Cyhoeddwyd 2015Artigo -
8
Effect of Urate-Lowering Therapy on All-Cause and Cardiovascular Mortality in Hyperuricemic Patients without Gout: A Case-Matched Cohort Study gan Jiunn‐Horng Chen, Joung‐Liang Lan, Chi‐Fung Cheng, Wen‐Miin Liang, Hsiao-Yi Lin, Gregory J. Tsay, Wen‐Ting Yeh, Wen‐Harn Pan
Cyhoeddwyd 2015Artigo -
9
-
10
TLC599 in patients with osteoarthritis of the knee: a phase IIa, randomized, placebo-controlled, dose-finding study gan David J. Hunter, Chi‐Ching Chang, James Cheng‐Chung Wei, Hsiao-Yi Lin, Carl Brown, Tien‐Tzu Tai, Chih‐Feng Wu, Wing Chia‐Ming Chuang, Sheue‐Fang Shih
Cyhoeddwyd 2022Artigo -
11
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption gan Wang Chang-yi, Wing-Wai Wong, Hung‐Chin Tsai, Yen‐Hsu Chen, Be-Sheng Kuo, Shugene Lynn, Jana Blažková, Katherine E. Clarridge, Hsiao-Wen Su, Chia-Ying Lin, Fan-Chen Tseng, Annie Lai, Fu-Hung Yang, Chen-Han Lin, William W. Tseng, Hsiao-Yi Lin, Connie L. Finstad, Flossie Wong‐Staal, Carl V. Hanson, Tae‐Wook Chun, Mei‐June Liao
Cyhoeddwyd 2019Artigo -
12
Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan gan Kuang‐Hui Yu, Der‐Yuan Chen, Jiunn‐Horng Chen, Shih‐Yang Chen, Shyh‐Ming Chen, Tien‐Tsai Cheng, Song‐Chou Hsieh, Tsu‐Yi Hsieh, Pai‐Feng Hsu, Chang‐Fu Kuo, Mei‐Chuan Kuo, Hing‐Chung Lam, I‐Te Lee, Toong‐Hua Liang, Hsiao‐Yi Lin, Shih‐Chang Lin, Wen‐Pin Tsai, Gregory J. Tsay, James Cheng‐Chung Wei, Chung‐Han Yang, Wen‐Chan Tsai
Cyhoeddwyd 2018Revisão -
13
Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition) gan Zhiyi Zhang, Cibo Huang, Quan Jiang, Yi Zheng, Yi Liu, Shengyun Liu, Yingjuan Chen, Yifang Mei, Changhai Ding, Min Chen, Xin Gu, Dan Xing, Min Gao, Lan He, Zhizhong Ye, Lijun Wu, Jianhua Xu, Pinting Yang, Xuewu Zhang, Yue Zhang, Jinwei Chen, Jin Lin, Like Zhao, Mengtao Li, Wanling Yang, Yixin Zhou, Qing Jiang, Cong‐Qiu Chu, Yaolong Chen, Weiya Zhang, Wei‐Chung Tsai, Guanghua Lei, Dongyi He, Wei Liu, Yongfei Fang, Darong Wu, Jianhao Lin, James Cheng‐Chung Wei, Hsiao-Yi Lin, Xiaofeng Zeng
Cyhoeddwyd 2020Revisão
Offerynnau Chwilio:
Pynciau Perthynol
Medicine
Internal medicine
Gout
Disease
Immunology
Pathology
Physical therapy
Alternative medicine
Cohort study
Confidence interval
Hyperuricemia
Intensive care medicine
Uric acid
Antibody
Cohort
Double blind
Endocrinology
Hazard ratio
Osteoarthritis
Placebo
Placebo-controlled study
Randomized controlled trial
Rheumatoid arthritis
Virus
Absolute risk reduction
Adalimumab
Adverse effect
Anakinra
Androgen
Anesthesia